Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

DESCRIBING AND MEASURING TOBACCO TREATMENT IN DRUG TREATMENT

Award Number: R21DA020489
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/20/2007
PERIOD OF PERFORMANCE END DATE: 06/30/2009

Group Awards By:

View Award Description

DESCRIBING AND MEASURING TOBACCO TREATMENT IN DRUG TREATMENT - DESCRIPTION (provided by applicant): Most people in treatment for drug abuse smoke cigarettes and many will die from tobacco-related illnesses. Some facilities are beginning to offer tobacco treatment, but little is known about the prevalence or quality of these services. The purpose of this project is to better understand how drug treatment facilities currently address tobacco and to develop a validated measure of tobacco treatment that is sensitive to change. This is the second revision to this application. In response to first-round reviewers, the application added an expert in scale development, provided more details on qualitative methods, and expanded qualitative and quantitative analyses. In response to second-round reviewers, this revision expands the study beyond methadone to include all types of outpatient substance abuse treatment facilities, restricts Phase I qualitative site visits to Kansas City substance abuse facilities, enlists the support/expertise of an organizational management researcher, and expands the array of organizational measures used. These changes enhance study generalizability, reduce year 1 costs and effort, and bring the study into line with the resources available through the R21 mechanism. There are three Specific Aims: 1. Identify why and how nicotine dependence services are offered, from the perspectives of staff and patients. Data will be collected using systems checklists and qualitative interviews at 8-12 Kansas City area drug treatment facilities representing a range of treatment types and levels of tobacco services. 2. Develop a Tobacco Treatment Survey (TTS), adapt for tobacco a measure of organizational readiness for change (ORC), and identify other organizational measures potentially related to tobacco treatment service provision. These measures will be based on site visit findings, a conceptual framework, and existing measures. 3. Test and refine the TTS and compare to organizational measures. The TTS, ORC, and other organizational measures will be phone-administered to a sample of 120 substance abuse treatment sites. The TTS will be refined through validity analyses and compared to the ORC and other organizational measures to identify potential aspects of facility climate and structure related to high and low rates of service provision. The project is innovative in that it adapts methods from health services and intervention research from multiple health care settings. This application will yield detailed descriptions of how services are offered in facilities and a validated measure of nicotine dependence services. These descriptions and measures will provide tools for identifying high- and low-service facilities, determine potential organizational factors related to service delivery, and support future research on tobacco treatment services in substance abuse treatment. People with mental illnesses, including alcohol and other drug problems, smoke 70% of the cigarettes consumed in the United States. The purpose of this project is to better understand how substance abuse treatment facilities currently address tobacco among their patients and to develop a validated measure of the types and quality of services provided. Project findings will support future policy and research to strengthen tobacco treatment services in substance abuse treatment. Public Health Relevance: This Public Health Relevance is not available.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2008 ( Subtotal = $171,071 )
2008	2008	UNIVERSITY OF KANSAS MEDICAL CENTER RESEARCH INSTITUTE	3901 RAINBOW BOULEVARD	KANSAS CITY	KS	66160	WYANDOTTE	USA	Drug Use and Addiction Research Programs	000	2	7/7/2008	NON-COMPETING CONTINUATION	$171,071
														Subtotal = $171,071

Issue Date FY: 2007 ( Subtotal = $209,475 )
2007	2007	UNIVERSITY OF KANSAS, MEDICAL CENTER	3901 RAINBOW BOULEVARD	KANSAS CITY	KS	66160	WYANDOTTE	USA	Drug Use and Addiction Research Programs	000	1	7/16/2007	NEW	$209,475
														Subtotal = $209,475

Grand Total All Awards = $380,546

Top

All Categories

About

Search

Reports

Data Submission

Award Information

DESCRIBING AND MEASURING TOBACCO TREATMENT IN DRUG TREATMENT

Award Number: R21DA020489

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/20/2007

PERIOD OF PERFORMANCE END DATE: 06/30/2009

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer